株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

メタボロミクス市場の世界市場予測 2021年:バイオマーカー & 創薬、ニュートリゲノミクス、毒性学

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors): Forecast to 2021

発行 MarketsandMarkets 商品コード 259317
出版日 ページ情報 英文 297 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
メタボロミクス市場の世界市場予測 2021年:バイオマーカー & 創薬、ニュートリゲノミクス、毒性学 Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors): Forecast to 2021
出版日: 2017年03月02日 ページ情報: 英文 297 Pages
概要

世界のメタボロミクス市場規模は、2016年から2021年の予測期間中に14.6%のCAGR (年間複合成長率) で推移し、2021年までに23億9,000万米ドルに達すると予測されています。メタボロミクス市場は主に、正確な疾病診断のニーズの高まり、オーダーメイド医療に対する需要の拡大、および先進技術の登場によって大きく成長しています。

当レポートでは、世界のメタボロミクス市場について調査し、製品・サービス、用途、適応症、および地域別の市場分析と予測、競合環境、および参入企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • メタボロミクス市場概要
  • アジア太平洋:メタボロミクス分離ツール市場、種類別
  • 地域概要:メタボロミクス市場
  • 地域ミックス:メタボロミクス市場
  • メタボロミクス市場:新興市場 vs. 先進市場

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会
    • 動向

第6章 重要考察

  • イントロダクション
  • 産業動向
  • 規制分析

第7章 技術投資の可能性

  • イントロダクション
  • 投資クライアントネットワーク
  • 資金団体/イニシアチブ
  • 戦略的評価を用いた技術投資の潜在的領域の分析
    • 新しい機会評価を検討するパラメーター
    • 機会の戦略的評価分析
    • 機会の説明

第8章 世界のメタボロミクス市場:製品・サービス別

  • イントロダクション
  • メタボロミクス装置
    • 分離ツール
    • 検出ツール
  • メタボロミクスバイオインフォマティクスツール・サービス
    • バイオインフォマティクスツール・データベース
    • バイオインフォマティクスツール・サービス

第9章 世界のメタボロミクス市場:用途別

  • イントロダクション
  • バイオマーカー創薬
  • 創薬
  • 毒性検査
  • ニュートリゲノミクス
  • 機能ゲノミクス
  • オーダーメイド医療
  • その他の用途

第10章 世界のメタボロミクス市場:適応症別

  • イントロダクション
  • 心血管疾患
  • 神経疾患
  • 先天性代謝異常症
  • その他の適応症

第11章 世界のメタボロミクス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の諸国

第12章 競合環境

  • 概要
  • 製品ポートフォリオ分析
  • 市場シェア分析
  • 競合状況・動向

第13章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC INC.
  • AGILENT TECHNOLOGIES, INC.
  • WATERS CORPORATION
  • DANAHER CORPORATION
  • 島津製作所
  • BIOCRATES LIFE SCIENCES AG
  • BIO-RAD LABORATORIES, INC.
  • BRUKER CORPORATION
  • HUMAN METABOLOME TECHNOLOGIES, INC.
  • LECO CORPORATION
  • METABOLON, INC.

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2550

The global metabolomics market is projected to reach USD 2.39 billion by 2021, at a CAGR of 14.6% during the forecast period of 2016 to 2021. The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.

In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Based on product and service, this market is further segmented into two major segments-metabolomics instruments and metabolomics bioinformatics tools & services. Based on metabolomics instruments, the market is further segmented into detection tools and separation tools. The separation tools segment commanded the largest share in the global metabolomics instruments market in 2015. The large share of this segment can be attributed to the ease of separation, characterization of metabolites, and quantitation of chemical compounds achieved by separation tools such as UPLC.

Based on application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.

In 2015, North America commanded the largest share of the metabolomics market, followed by Europe. The U.S. is the prime market for metabolomics due to the rising acceptance of personalized medicines and growing focus of stakeholders on research projects involving metabolites, amino acid composition, and associated biomolecules in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Major players in the global metabolomics market are Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.).

Research Coverage:

  • Detailed insights on all the submarkets, based on metabolomics instruments (Gas Chromatography, Capillary Electrophoresis, High-performance Liquid Chromatography, Ultra-performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, and Surface-based Mass Analysis), this can help market players to identify high growth segments in the metabolomics market.
  • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.
  • Key insights and market sizing for the different end users of the metabolomics market namely, hospitals, laboratories, academic institutes, biotechnology firms, clinical research laboratories, and other end users.
  • Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product & service, technology, application, and indication areas; the market size numbers provided in the report will also enable players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.
  • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the metabolomics market. The report analyzes the market by product & service, application, and indication
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the metabolomics market
  • Market Development: Comprehensive information on lucrative emerging markets, based on product & service, application, indication, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the metabolomics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the metabolomics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY RESEARCH
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. METABOLOMICS MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC: METABOLOMICS SEPARATION TOOLS MARKET, BY TYPE
  • 4.3. GEOGRAPHIC SNAPSHOT: METABOLOMICS MARKET
  • 4.4. GEOGRAPHIC MIX: METABOLOMICS MARKET
  • 4.5. METABOLOMICS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Availability of government and private funding
      • 5.2.1.2. Increasing pharmaceutical and biotech R&D expenditure
      • 5.2.1.3. Technological advancements
      • 5.2.1.4. Growing demand for personalized medicine
      • 5.2.1.5. Increasing use of metabolomics in toxicology testing
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. Issues related to data examination and processing
      • 5.2.2.2. High cost of tools and instruments
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Biomarker development
      • 5.2.3.2. Rapid growth opportunities in emerging markets
    • 5.2.4. KEY MARKET CHALLENGES
      • 5.2.4.1. Complexity and diversity of biological samples
      • 5.2.4.2. Dearth of skilled researchers

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
    • 6.2.2. TIE-UPS BETWEEN INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS
  • 6.3. REGULATORY ANALYSIS

7. TECHNOLOGY INVESTMENT POTENTIAL

  • 7.1. INTRODUCTION
  • 7.2. INVESTMENT CLIENT NETWORKS
  • 7.3. FUNDING BODIES/INITIATIVES (2012-2016)
  • 7.4. ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION
    • 7.4.1. PARAMETERS CONSIDERED FOR EMERGING OPPORTUNITY EVALUATION
      • 7.4.1.1. Level of attractiveness
      • 7.4.1.2. Probability of success
    • 7.4.2. OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
    • 7.4.3. DESCRIPTION OF OPPORTUNITIES
      • 7.4.3.1. Viable (Quadrant 1) - Biomarker discovery and lead optimization in drug discovery
        • 7.4.3.1.1. Biomarker Discovery
        • 7.4.3.1.2. Lead Optimization in Drug Discovery
        • 7.4.3.1.3. Toxicity Testing
      • 7.4.3.2. Promising (Quadrant 2) - Companion diagnostics for personalized medicine and nutrigenomics
        • 7.4.3.2.1. Companion Diagnostics for Personalized Medicine
        • 7.4.3.2.2. Nutrigenomics
        • 7.4.3.2.3. Agriculture
      • 7.4.3.3. Challenging (Quadrant 3) - Environmental metabolomics
        • 7.4.3.3.1. Environmental Metabolomics
        • 7.4.3.3.2. Functional Genomics

8. GLOBAL METABOLOMICS MARKET, BY PRODUCT AND SERVICE

  • 8.1. INTRODUCTION
  • 8.2. METABOLOMICS INSTRUMENTS
    • 8.2.1. SEPARATION TOOLS
      • 8.2.1.1. High-Performance Liquid Chromatography
      • 8.2.1.2. Gas Chromatography
      • 8.2.1.3. Ultra-Performance Liquid Chromatography
      • 8.2.1.4. Capillary Electrophoresis
    • 8.2.2. DETECTION TOOLS
      • 8.2.2.1. Mass Spectrometry
      • 8.2.2.2. Nuclear Magnetic Resonance Spectroscopy
      • 8.2.2.3. Surface-Based Mass Analysis
  • 8.3. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
    • 8.3.1. BIOINFORMATICS TOOLS & DATABASES
    • 8.3.2. BIOINFORMATICS SERVICES

9. GLOBAL METABOLOMICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. BIOMARKER DISCOVERY
  • 9.3. DRUG DISCOVERY
  • 9.4. TOXICOLOGY TESTING
  • 9.5. NUTRIGENOMICS
  • 9.6. FUNCTIONAL GENOMICS
  • 9.7. PERSONALIZED MEDICINE
  • 9.8. OTHER APPLICATIONS

10. GLOBAL METABOLOMICS MARKET, BY INDICATION

  • 10.1. INTRODUCTION
  • 10.2. CANCER
  • 10.3. CARDIOVASCULAR DISORDERS
  • 10.4. NEUROLOGICAL DISORDERS
  • 10.5. INBORN ERRORS OF METABOLISM
  • 10.6. OTHER INDICATIONS

11. GLOBAL METABOLOMICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF APAC
  • 11.5. LATIN AMERICA
    • 11.5.1. BRAZIL
    • 11.5.2. MEXICO
    • 11.5.3. REST OF LATIN AMERICA
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. PRODUCT PORTFOLIO ANALYSIS
  • 12.3. MARKET SHARE ANALYSIS
  • 12.4. COMPETITIVE SITUATIONS AND TRENDS
    • 12.4.1. PRODUCT LAUNCHES AND ENHANCEMENTS
    • 12.4.2. PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES
    • 12.4.3. EXPANSIONS
    • 12.4.4. ACQUISITIONS AND DIVESTITURES

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. INTRODUCTION
  • 13.2. THERMO FISHER SCIENTIFIC INC.
  • 13.3. AGILENT TECHNOLOGIES, INC.
  • 13.4. WATERS CORPORATION
  • 13.5. DANAHER CORPORATION
  • 13.6. SHIMADZU CORPORATION
  • 13.7. BIOCRATES LIFE SCIENCES AG
  • 13.8. BIO-RAD LABORATORIES, INC.
  • 13.9. BRUKER CORPORATION
  • 13.10. HUMAN METABOLOME TECHNOLOGIES, INC.
  • 13.11. LECO CORPORATION
  • 13.12. METABOLON, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL METABOLOMICS MARKET SNAPSHOT
  • TABLE 2: AVAILABILITY OF GOVERNMENT AND PRIVATE FUNDING TO DRIVE THE MARKET GROWTH
  • TABLE 3: ISSUES RELATED TO DATA EXAMINATION AND PROCESSING TO RESTRAIN MARKET GROWTH
  • TABLE 4: BIOMARKER DEVELOPMENT TO OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET GROWTH
  • TABLE 5: DEARTH OF SKILLED RESEARCHERS IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 6: INTEGRATED ANALYTICAL INSTRUMENTS LAUNCHED BETWEEN 2013 AND 2016.
  • TABLE 7: REGULATORY STANDARD/APPROVAL REQUIRED FOR METABOLOMICS PRODUCTS, BY COUNTRY/REGION
  • TABLE 8: GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL GAS CHROMATOGRAPHY SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL BIOINFORMATICS TOOLS & DATABASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL METABOLOMICS MARKET SIZE FOR BIOMARKER DISCOVERY APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL METABOLOMICS MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL METABOLOMICS MARKET SIZE FOR TOXICOLOGY TESTING APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL METABOLOMICS MARKET SIZE FOR NUTRIGENOMIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL METABOLOMICS MARKET SIZE FOR FUNCTIONAL GENOMIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL METABOLOMICS MARKET SIZE FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL METABOLOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL METABOLOMICS MARKET SIZE FOR CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL METABOLOMICS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL METABOLOMICS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL METABOLOMICS MARKET SIZE FOR INBORN ERRORS OF METABOLISM, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL METABOLOMICS MARKET SIZE FOR OTHER INDICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 50: U.S.: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: U.S.: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: U.S.: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: U.S.: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: U.S.: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: U.S.: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 56: CANADA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 57: CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: CANADA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: CANADA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: CANADA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: CANADA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: METABOLOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 65: EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: EUROPE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: EUROPE: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 71: GERMANY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 72: GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: GERMANY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: GERMANY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: GERMANY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 77: GERMANY: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 78: U.K.: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 79: U.K.: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: U.K.: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: U.K.: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: U.K.: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: U.K.: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 84: U.K.: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 85: FRANCE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 86: FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: FRANCE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: FRANCE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: FRANCE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: FRANCE: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 92: ITALY: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 93: ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: ITALY: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: ITALY: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: ITALY: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 98: ITALY: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 99: SPAIN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 100: SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: SPAIN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: SPAIN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: SPAIN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: SPAIN: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 106: REST OF EUROPE: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 107: ROE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: ROE: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: ROE: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: ROE: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 112: ROE: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 113: ASIA-PACIFIC: METABOLOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 114: ASIA-PACIFIC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 115: ASIA-PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: ASIA-PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 117: ASIA-PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: ASIA-PACIFIC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: ASIA-PACIFIC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 120: ASIA-PACIFIC: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 121: JAPAN: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 122: JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: JAPAN: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: JAPAN: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: JAPAN: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 127: JAPAN: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 128: CHINA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 129: CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: CHINA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: CHINA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: CHINA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 134: CHINA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 135: INDIA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 136: INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 137: INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 138: INDIA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 139: INDIA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: INDIA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 141: INDIA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 142: ROAPAC: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 143: ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 144: ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: ROAPAC: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 146: ROAPAC: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: ROAPAC: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 148: ROAPAC: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 149: LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 150: LATIN AMERICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 151: LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 152: LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 153: LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 154: LATIN AMERICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 155: LATIN AMERICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 156: LATIN AMERICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 157: BRAZIL: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 158: BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 159: BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 160: BRAZIL: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 161: BRAZIL: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 162: BRAZIL: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 163: BRAZIL: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 164: MEXICO: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 165: MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 166: MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 167: MEXICO: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 168: MEXICO: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 169: MEXICO: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 170: MEXICO: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 171: ROLA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 172: ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 173: ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 174: ROLA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 175: ROLA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 176: ROLA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 177: ROLA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 178: MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 179: MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 180: MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR SEPARATION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 181: MIDDLE EAST & AFRICA: METABOLOMICS INSTRUMENTS MARKET SIZE FOR DETECTION TOOLS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 182: MIDDLE EAST & AFRICA: METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 184: MIDDLE EAST & AFRICA: METABOLOMICS MARKET SIZE, BY INDICATION, 2014-2021 (USD MILLION)
  • TABLE 185: GROWTH STRATEGY MATRIX (JANUARY 2013-NOVEMBER 2016)
  • TABLE 186: PRODUCT PORTFOLIO ANALYSIS: METABOLOMICS MARKET
  • TABLE 187: PRODUCT LAUNCHES AND ENHANCEMENTS, 2013-2016
  • TABLE 188: PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES, 2013-2016
  • TABLE 189: EXPANSIONS, 2013-2016
  • TABLE 190: ACQUISITIONS AND DIVESTITURES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL METABOLOMICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL METABOLOMICS SEPARATION TOOLS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL METABOLOMICS DETECTION TOOLS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL METABOLOMICS MARKET FOR BIOINFORMATICS TOOLS AND SERVICES, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GLOBAL METABOLOMICS MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: GLOBAL METABOLOMICS MARKET, BY INDICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: ASIA-PACIFIC TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: AVAILABILITY OF GOVERNMENT AND PRIVATE FUNDING FOR RESEARCH IS DRIVING GROWTH OF THE METABOLOMICS MARKET
  • FIGURE 15: HPLC COMMANDED THE LARGEST SHARE OF THE ASIA-PACIFIC METABOLOMICS SEPARATION TOOLS MARKET IN 2015
  • FIGURE 16: U.S. DOMINATED THE GLOBAL METABOLOMICS MARKET IN 2015
  • FIGURE 17: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 18: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: METABOLOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: R&D EXPENDITURE OF TOP BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2012-2014
  • FIGURE 21: GLOBAL METABOLOMICS MARKET- INVESTMENT CLIENT NETWORK
  • FIGURE 22: OPPORTUNITY STRATEGIC EVALUATION ANALYSIS OF METABOLOMICS IN VARIOUS APPLICATIONS AREAS
  • FIGURE 23: METABOLOMICS INSTRUMENTS DOMINATED THE MARKET IN 2016
  • FIGURE 24: BIOMARKER DISCOVERY TO DOMINATE THE METABOLOMICS APPLICATIONS MARKET IN 2016
  • FIGURE 25: CANCER INDICATION TO DOMINATE THE MARKET IN 2016
  • FIGURE 26: GLOBAL METABOLOMICS MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 27: NORTH AMERICA: METABOLOMICS MARKET SNAPSHOT
  • FIGURE 28: EUROPE: METABOLOMICS MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: METABOLOMICS MARKET SNAPSHOT
  • FIGURE 30: KEY DEVELOPMENTS IN THE METABOLOMICS MARKET, 2013-2016
  • FIGURE 31: GLOBAL METABOLOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 32: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & ENHANCEMENTS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF THE MAJOR PLAYERS IN THE METABOLOMICS MARKET
  • FIGURE 34: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 35: COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC.: (2015)
  • FIGURE 36: WATERS CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 37: DANAHER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 38: SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 39: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 40: BRUKER CORPORATION: COMPANY SNAPSHOT (2015)
Back to Top